Investors and readers
Holders and anyone weighing an RWA product.
Now
- Follow cases by RSS
- Repeat the "check it yourself" steps
- Tell us what we missed
Later
- Comment on cases and product pages
- Email alerts per product
- "I want to know too" counter
Every case note can be checked, answered and challenged. Investors, issuers, technical reviewers, journalists and researchers each have a way in. What you contribute is published under your name or a pseudonym, and results that contradict us are published too.
Facts, sources and questions go to the issuer before anything is public.
Issuer can correct factsThe case note goes live with any comments received so far.
Everyone can read, check and citeReplies are published in full. No reply is recorded as such.
Issuer replies; reviewers checkThe case stays open and the record shows the wait.
Late replies are always addedExplained, corrected, disputed or unresolved. New evidence can reopen a case.
We correct our own errors in publicHolders and anyone weighing an RWA product.
Teams named in a case, and those who want to disclose more.
Analysts and engineers who can reproduce a figure.
Anyone who has spotted a discrepancy.
Reporters and editors covering tokenization.
Academics, students and course leaders.
Data platforms, custodians, transfer agents, oracles.
Native speakers of French, Arabic or Chinese.
Give the source for every statement. Hearsay is not accepted.
Describe what the documents and the chain show. Do not speculate about motive.
Do not access non-public systems or approach issuer staff under a false identity.
Say whether you hold the product or work for the issuer or a competitor.
Checks and tips are reviewed against these rules. Comments appear at once and are handled after posting: reported or rule-breaking comments are removed with a note.
Empty until the first contribution is published.
No payment from issuers for reviews. No bounties for now. No "scam" labels: descriptive disclosure grades and factual event markers instead. No credit opinions or ESG scores at this stage. No product named before its issuer has been notified.
Online forms open with the first published case. Until then, write to us.